Page 1

According to the report Global Anti-Venom Market, published by Market Data Forecast, the global market is projected to reach USD 1493.2 million by 2021, at a CAGR of 6.12% from 2016 to 2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 100,000 people die worldwide with snake bites annually. To overcome poisonous effects after venomous bites the global manufacturers developed number of Antivenom products including vaccines and hyperimmune sera. Browse market data tables and in-depth TOC of the Global Anti-Venom Market to 2021 @ http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/

Increasing government initiations to promote the development of high quality antivenom products, presence of highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch are driving the growth of global Antivenom Market. In addition, growing of deaths from venomous animal’s bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market. However, withdrawal of antivenom products, insufficient funding to develop the antivenom products to meet demand, high cost of the products, regulatory complexities, and high costs of maintaining livestock for antivenom production are restraining the growth of global Antivenom Market. The Global market for Antivenom is broadly categorized into type and animal. On the basis of type, global Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the dominating market for Antivenom accounting for a share of approximately 39.0% followed by Europe in 2016. Asia-Pacific is estimated to be the fastest growing region with a CAGR of 8.59% during the forecast period of 2016-2021. Free sample of the report is available @http://www.marketdataforecast.com/marketreports/global-antivenom-market-1580/request-sample Key market players in the global Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts


Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India). Market Segmentation 1) Type • • •

• • •

Introduction Vaccines Hyperimmune Sera • Homologous • Heterologous Growth Analysis, By type Attractiveness Analysis, By Type Market Share Analysis, By Type

• • • • • • • •

Introduction Snakes Scorpions Spiders Others Y-o-Y Growth Analysis, By Animal Market Attractiveness Analysis, By Animal Market Share Analysis, By Animal

2) Animal

Reasons to buy Global Anti-venom Market Research Report: • Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering • Segment-level analysis on basis of product type, application, color along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment


• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market Inquire before Buying at http://www.marketdataforecast.com/market-reports/global-antivenommarket-1580/inquire About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Global antivenom market  

The Global Antivenom Market is expected to reach USD 1,584.5 million by 2022 from USD 1,177.4 million in 2017, growing at a CAGR of 6.12% du...

Global antivenom market  

The Global Antivenom Market is expected to reach USD 1,584.5 million by 2022 from USD 1,177.4 million in 2017, growing at a CAGR of 6.12% du...

Advertisement